Bridgeway Capital Management, LLC Karyopharm Therapeutics Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.44 Billion
- Q3 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 239,500 shares of KPTI stock, worth $167,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
239,500
Previous 264,500
9.45%
Holding current value
$167,650
Previous $230,000
13.91%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding KPTI
# of Institutions
98Shares Held
57.6MCall Options Held
258KPut Options Held
81.2K-
Vanguard Group Inc Valley Forge, PA7.65MShares$5.36 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY5.55MShares$3.88 Million0.36% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.1MShares$3.57 Million0.58% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.32MShares$3.02 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$2.92 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $55.9M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...